Informational Webinar for Alzheimer's Disease Related Dementia (ADRD) Funding Opportunity Announcements (FOAs) for PAR-18-661, RFA-NS-18-015, RFA-NS-18-025 and RFA-NS-18-024

Notice Number: NOT-NS-18-050

Key Dates
Release Date: March 15, 2018

Related Announcements

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)


The National Institute for Neurological Disorders and Stroke (NINDS) will hold a pre-application informational webinar on March 19th, 2018 from 1:00-2:00 pm ET for the following Funding Opportunity Announcements (FOAs):

  • PAR-18-661 Pathway and Target Identification for Alzheimer's Disease Related Dementias (ADRDs) (U01 Clinical Trial Not Allowed)
  • RFA-NS-18-015 Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (U01 Clinical Trial Not Allowed)
  • RFA-NS-18-025 Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 - Clinical Trial Optional)
  • RFA-NS-18-024 Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)

The webinar will provide a brief introduction to each FOA and highlight key components and requirements of the different phases of the grant mechanisms.

Information on how to join the webinar (video and audio coordinates, including passwords) is provided below:

Join Webinar Meeting | 622 274 563

Join by phone
1-650-479-3208 Call-in toll number (US/Canada)
Access code: 622 274 563
Global call-in numbers

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application.


Please direct all inquiries to:

Margaret Sutherland, PhD
Program Director
National Institute of Neurological Disorders and Stroke
Telephone: 301-496-5680